UnitedHealth (UNH)

The Apex Times

THE APEX TIMES

Jim Cramer tells viewers to “buy it” in UnitedHealth stock call, sparking fresh debate among investors

The Mad Money host’s latest on-air push for UnitedHealth Group shares centers on whether the company’s defensive healthcare profile can still deliver, even as investors weigh changing cost and policy pressures.

The Apex Times

THE APEX TIMES

UnitedHealth’s UNH: Analysts Turn Optimistic, but Skepticism Surfaces Over How Much It Matters

A fresh Wall Street note points to an “average brokerage recommendation” announcement that implies UnitedHealth shares should be added, even as the commentary raises questions about whether investor optimism has been reliable for the company’s business outlook.

The Apex Times

THE APEX TIMES

UnitedHealth units face proposed FTC settlement tied to alleged insulin rebate practices

The Federal Trade Commission says OptumRx and Emisar Pharma Services were involved in conduct it viewed as anticompetitive in insulin rebates, leading to a proposed settlement with UnitedHealth Group.

The Apex Times

THE APEX TIMES

UnitedHealth’s broader platform, AI push and earnings momentum draw a line versus Humana’s Medicare focus, in a fresh market comparison

A June 22 analysis weighing UNH and HUM argues that UnitedHealth’s diversified business model and investment priorities may put it in a stronger position than its Medicare-heavy rival, even as both remain tied to the same underlying healthcare cost pressures.

The Apex Times

THE APEX TIMES

UnitedHealth outlines a $3 billion AI push aimed at reducing costs and boosting returns

The insurer says its artificial intelligence efforts are producing roughly 2-to-1 returns and projects near-term operating-cost relief of almost $1 billion this year as it scales new automation across care delivery and administration.

The Apex Times

THE APEX TIMES

UnitedHealth says its subsidiaries took a major step toward settling an FTC insulin pricing dispute

The move, described in a June 12 action by UnitedHealth Group subsidiaries, targets an ongoing dispute with the Federal Trade Commission over insulin pricing practices. What remains unclear is the specific agreement terms and timing of any settlement.

The Apex Times

THE APEX TIMES

Jim Cramer Says Clover Health Could Be a Speculative Bet, But He’s Still Backing UnitedHealth and CVS

On CNBC’s Mad Money, the host told viewers to pay attention to where a stock is headed, not just where it has been, while naming Clover Health as a watchlist idea and citing UnitedHealth and CVS as preferred picks.

The Apex Times

THE APEX TIMES

UnitedHealth (UNH) draws heightened investor attention after renewed retail focus on earnings outlook

A market note circulating on Yahoo Finance says Zacks.com users are paying closer attention to UnitedHealth’s stock, prompting investors to re-check what may be driving expectations for the insurer’s near-term performance.